Corifollitropin alfa: all 40 studies that test it

Page 1 of 1. Open to participants first (2), then studies with results posted, then the rest; newest registration first within each.

• Usefulness of Corifollitropin α as Alternative to Conventional Daily rFSH Protocols in Oocyte Donors Undergoing Pituitary Suppression With Medroxiprogesterona Acetate (MPA)RecruitingNCT06193135Not applicable
• PPOS (Progestin Primed Ovarian Stimulation) and Corifollitropin Alfa (CFA) Cross-over StudyRecruitingNCT06175832Phase 4
• Continuous Double Ovarian Stimulation.CompletedNCT05815719Phase 4Results posted
• Efficacy and Safety of Corifollitropin Alfa (MK-8962) in Combination With Human Chorionic Gonadotropin (hCG) in Adolescent Males With Hypogonadotropic Hypogonadism (HH) (MK-8962-043)CompletedNCT03019575Phase 3Results posted
• Efficacy of Corifollitropin Alfa in Obese Women in Terms of Clinical and Molecular Parameters of IVF SuccessCompletedNCT02606500Phase 4Results posted
• A Study of the Efficacy and Safety of Corifollitropin Alfa (MK-8962) in Combination With Human Chorionic Gonadotropin (hCG) in Adult Men With Hypogonadotropic Hypogonadism (HH) (P07937)CompletedNCT01709331Phase 3Results posted
• Frozen-thawed Embryo Transfer (FTET) Cycle Follow-up Protocol (P06031)CompletedNCT01146418Phase 3Results posted
• Efficacy and Safety Study of a Single Injection of SCH 900962 Versus Daily recFSH Injections in Women Undergoing Controlled Ovarian Stimulation (Study P06029)CompletedNCT01144416Phase 3Results posted
• To Investigate Efficacy and Safety of a Single Injection of Org 36286 for Ovarian Stimulation Using Daily Recombinant FSH as Reference (Ensure)(P05690/MK-8962-001)CompletedNCT00702845Phase 3Results posted
• Corifollitropin Alfa in Participants Undergoing Repeated Controlled Ovarian Stimulation (COS) Cycles Using a Multiple Dose Gonadatropin Releasing Hormone (GnRH) Antagonist Protocol (Study 38825)(P05714)CompletedNCT00696878Phase 3Results posted
• A Study to Investigate the Efficacy and Safety of a Single Injection of Corifollitropin Alfa (Organon 36286) for Ovarian Stimulation Using Daily Recombinant Follicle Stimulating Hormone (FSH) as Reference (P05787)CompletedNCT00696800Phase 3Results posted
• One-shot Ovarian Stimulation Protocol (One-shot)CompletedNCT06635538Not applicable
• Comparison of Sequential CFA vs CFA +rFSH for Elective Fertility Preservation.CompletedNCT06134479Phase 3
• Reduction of Progesterone Elevation at Trigger in POR After Long Acting COS Compared With Daily COS: a Prospective Randomized TrialCompletedNCT04695483Phase 4
• Corifollitropin Alpha and Ovarian ResponseCompletedNCT04416607Not applicable
• Prospective Randomized Trial Comparing Corifollitropin-alfa Late Start vs. Corifollitropin-alfa Standard Start in Expected Poor, Normal and High-responders Undergoing IVFCompletedNCT03816670Not applicable
• Effect of Different Ovarian Stimulation Protocols on Endometrial ReceptivityCompletedNCT03755973Phase 4
• Optimisation of Follicular Recruitment in IVM CyclesCompletedNCT03197077Phase 3
• Corifollitropin Alfa Combined With Menotropin Versus Follitropin and Lutropin Alfa in Expected Suboptimal RespondersCompletedNCT03177538Phase 4
• Desogestrel (DSG) and Corifollitropin(FSH-CTP) Alfa for Ovarian Stimulation in DonorsWithdrawnNCT02757287Phase 4
• Corifollitropin Alfa on D5 Versus D7 After Contraceptive PillCompletedNCT02490150Phase 4
• Corifollitropin Alfa Versus Follitropin Beta in High RespondersStatus unknownNCT02471677Phase 4
• Efficacy of Corifollitropin Alfa Versus Follitropin Beta in Aged IVF (In-vitro Fertilization) PatientsCompletedNCT02466204Phase 4
• Ovarian Stimulation Single Injection ElonvaCompletedNCT02414737Phase 3
• Type of Gonadotropin and Embryo Kinetics of DevelopmentTerminatedNCT02402192Phase 4
• Corifollitropin Alfa Versus Daily rFSH in the Controlled Ovarian Stimulation of Poor RespondersTerminatedNCT02254928Phase 4
• Corifollitropin Alfa Application in PCOS PatientsStatus unknownNCT02215135Phase 4
• Use of Corifolitropin Alfa in Oocyte DonorsStatus unknownNCT02213627Phase 4
• Corifollitropin Alfa Compared to Daily rFSH in Poor Responders Undergoing ICSICompletedNCT02046655Phase 4
• Corifollitropin Alfa Followed by Menotropin for Poor Ovarian Responders TrialCompletedNCT01816321Phase 3
• Corifollitropin Alfa Followed by hpHMG in a Long GnRH Agonist Protocol for the Treatment of Poor Ovarian RespondersCompletedNCT01732094Phase 2
• Treatment of Poor Ovarian Responders With Corifollitropin Alfa Followed by hpHMG in a Short GnRH Agonist ProtocolCompletedNCT01732068Phase 2
• D2 Versus D4 Corifollitropin Alfa in GnRH AntagonistsCompletedNCT01633580Phase 4
• An Efficacy and Safety Study of Corifollitropin Alfa (MK-8962) in Contrast to Recombinant FSH for Use in Controlled Ovarian Stimulation of Indian Women (P07056, Also Known as MK-8962-029)WithdrawnNCT01599494Phase 3
• Corifollitropin Alfa Versus Recombinant Follicle Stimulating Hormone (FSH) in Ovarian Stimulation of Women Undergoing in Vitro FertilisationCompletedNCT01319695Phase 1/2
• Investigate Dose of Org 36286 to Initiate Multiple Follicular Growth in a Controlled Ovarian Hyperstimulation Protocol for IVF or IVF/ICSI (P07015)CompletedNCT00702806Phase 2
• Study to Investigate the Optimal Dose of Org 36286 to Induce Monofollicular Ovulation in Women With WHO Group II Anovulatory Infertility (P07016)CompletedNCT00702585Phase 2
• A Trial of Single Dose Corifollitropin Alfa's Ability to Induce Multiple Follicular Growth During the First Week of Controlled Ovarian Stimulation for IVF or ICSI (38833)(P05788)CompletedNCT00702351Phase 2
• An Open-label, Single Center Trial to Assess the Pharmacokinetics, Pharmacodynamics and Safety of Org 36286 (P07004)CompletedNCT00647933Phase 1
• A Phase 2, Trial to Investigate the Dose-Response Relationship of a Single Injection of Org 36286 (Corifollitropin Alfa) to Initiate Multiple Follicular Growth in a Controlled Ovarian (Study 38826)(P06055)(COMPLETED)CompletedNCT00598208Phase 2

← Corifollitropin alfa overview